- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2021–2026 · research · R01
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state
Cigall Kadoch · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Development of microRNA (miR)-based cell-targeted polymeric nanoparticles for myeloma therapy
Ruben D Carrasco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2023 · grant · Standard Grant
Collaborative Research: FET: Medium: Biological production and enzymatic processing for defect-free, scalable nucleic-acid circuits
William Shih · Dana-Farber Cancer Institute · funded by National Science Foundation
2021 · research · Essential Open Source Software for Science (EOSS)
Improving Computational Methods for High-throughput Sequence Data Analysis
Heng Li · Dana-Farber Cancer Institute · funded by Chan Zuckerberg Initiative
2021–2024 · research · R21
Exploring alternate targets for inhibition of virus infection by PPI disruption
Michael A Calderwood · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · career development · K08
Can a subset of patients with HER2+ metastatic breast cancer be cured?
Heather Anne Parsons · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2025 · research · R01
A Stakeholder Informed Randomized Trial of Pretest Video Education vs Standard Genetic Counseling for Cancer Patients: Evaluating the Impact on Patients, Providers and Practices
Huma Q Rana · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications
Birgit Knoechel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2025 · grant · PRMRP
Development of DF-COV for the Treatment and Prevention of COVID-19 and Associated Immunopathologic Respiratory Complications
Gordon Freeman · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2021–2026 · research · R35
Mechanisms of eIF3-mediated translation regulation
Amy Si-Ying Lee · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R35
Mechanisms of eIF3-mediated translation regulation
Amy Si-Ying Lee · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2022 · career development · K07
COVID Extension: Material Hardship as a Targetable Measure of Poverty in Pediatric Cancer
Kira O. Bona · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2024 · cooperative agreement · U54
The Center for Therapeutic Targeting of EWS-oncoproteins
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Development, Optimization and Preclinical Modeling of Hematopoietic Stem Cell Gene Editing for the Treatment of RAG1 Immunodeficiency
Pietro Genovese · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state
Cigall Kadoch · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · career development · K08
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
Tao Zou · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial
Ting Bao · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2025 · grant · PCRP
Blood-Based Epigenomic Correlates of Aggressive Prostate Cancer Phenotypes
Sylvan Baca · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2021–2024 · research · R01
Statistical Methods and Validation Analyses for the Integration of External Data in Clinical Trials
Lorenzo Trippa · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2024 · award
Mechanistic interrogation of BIRC6 vulnerability in carcinomas
Lisa Cervia · Dana-Farber Cancer Institute · funded by American Cancer Society
2021–2025 · research · R01
Scaling up tobacco control in India: Comparing smartphone to in-person training for implementing an evidence-based intervention to reduce tobacco use among schoolteachers
Eve M Nagler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
Thanh Uyen Barbie · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2025 · research · R01
Statistical Methods and Validation Analyses for the Integration of External Data in Clinical Trials
Lorenzo Trippa · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2024 · research · R01
DMS/NIGMS 1: Statistical modeling and estimation of cellular population dynamics
Thomas Mcdonald · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2025 · research · R01
Scaling up tobacco control in India: Comparing smartphone to in-person training for implementing an evidence-based intervention to reduce tobacco use among schoolteachers
Eve M Nagler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2023 · career development · K99
Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia
Shan Lin · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Tracing the lineage histories and differentiation trajectories of individual cancer cells in myeloproliferative neoplasms
Sahand Hormoz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2024 · grant · PCRP
Functionally Characterizing the Noncoding Genome of Metastatic Prostate Cancer to Identify Therapeutic Vulnerabilities
Matthew Freedman · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2021–2025 · research · R01
Tracing the lineage histories and differentiation trajectories of individual cancer cells in myeloproliferative neoplasms
Sahand Hormoz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2024 · grant · PRCRP
Intervening in the TP53 Pathway Phosphatome in Pediatric High-Grade Gliomas
Rameen Beroukhim · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2021–2026 · grant · DP2
How the 3D Architecture of the Brain Shapes Cancer Cell Fate Decisions
Mariella Gruber Filbin · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · grant · DP2
Hijacking the T cell machinery for logic-gated CAR T cell control
Robbie G. Majzner · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · career development · K08
Investigating Transcriptional Elongation and Nuclear RNA Surveillance in Melanoma
Megan Leigh Insco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches
Matthew L Freedman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
Thanh Uyen Barbie · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2023 · fellowship · F32
Mechanisms and therapeutic evaluation of splicing modulation for cohesin-mutant myelodysplastic syndromes
Emily Wheeler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R35
Mechanisms of eIF3-mediated translation regulation
Amy Si-Ying Lee · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · career development · K08
Insights from somatic genomics lead to novel therapeutic targets in inherited bone marrow failure syndromes: Shwachman-Diamond Syndrome as a model.
Alyssa Kennedy · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2022 · career development · K99
A pan-cancer atlas of driver mutations in >100,000 patients based on a hypothesis-driven combined computational and experimental approach
Felix Dietlein · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2024 · research · R01
Statistical Methods and Validation Analyses for the Integration of External Data in Clinical Trials
Lorenzo Trippa · Dana-Farber Cancer Institute · funded by National Institutes of Health
